B.C.'s Applied Biologicals Commercializes R&D With Government Support
Applied Biological Materials Inc. of British Columbia has succeeded in commercializing a new detection system for genetic information.
Location Canada 2011
The company has developed a microRNA (miRNA) expression and detection system where miRNA is known to regulate the genome, which is the basic foundation for human health and medical conditions. The system is used in life science research and biotechnology industries across Canada and the world.
"Research in miRNA holds great promise for the life science community and can ultimately contribute to innovative diagnostic assays and therapeutic modalities. Through government of Canada support, Applied Biological Materials Inc. has been elevated to become one of the world's top players in this technology," said CEO Dr. Peter Li. "Our dominant position has opened and will continue to open new job opportunities in Canada. In short, it is almost impossible for Applied Biological Materials Inc. to take on cutting-edge research and development, like the miRNA project, without the government's support."
Project Announcements
Minth Group Plans Windsor, Ontario, Canada, Manufacturing Operations
04/07/2025
Siemens Canada Expands Oakville, Ontario, Operations
04/03/2025
Crust Craft Expands Edmonton, Alberta, Canada, Production Operations
03/27/2025
Frontier Lithium Plans Thunder Bay, Ontario, Canada, Chemical Production Operations
03/10/2025
Linamar Corporation Expands Ontario, Canada, Production Operations
02/03/2025
NEO Battery Materials Plans Windsor, Ontario, Canada, Silicon Anode Operations
01/28/2025
Most Read
-
Run a Job Task Analysis
Q4 2024
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
The Location Economics of Advanced Nuclear
Q1 2025
-
Why Workforce Readiness Can’t Wait
Q1 2025
-
Power, Policy, and Site Selection in 2025
Q1 2025
-
Is It Time to Start Planning for Quantum Data Centers?
Q1 2025
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024